NEU 2.50% $15.59 neuren pharmaceuticals limited

Ann: Shareholders provide further support for Rett syndrome, page-22

  1. 194 Posts.
    it is in the shareholders best interest to obtain the best price for the CR if the trial is successful they should of waited until after the results were released to obtain best price. Instread of 9 cents it could of been 15 cents. Work it out smartie
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.